Hearing loss with semicircular canal fistula in exotoxin A-deficient Pseudomonas otitis media

Otolaryngology - Head and Neck Surgery

Volumn 130, Issue 4, 2004, Pages 430-436

  Yunus, Tariq M ^a,b   Molina, Rolando M ^a,c   Prevatt, Angela R ^a   Gajewski, Byron J ^d   Sedwick, Jack D ^a   Antonelli, Patrick J ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF OKLAHOMA   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ENROFLOXACIN; EXOTOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; GUINEA PIG; HEARING; HEARING LOSS; MALE; NONHUMAN; OTITIS MEDIA; PSEUDOMONAS; SEMICIRCULAR CANAL; STATISTICAL SIGNIFICANCE;

EID: 1942510506     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otohns.2003.12.019     Document Type: Article

References (20)

1. Gacek RR. The surgical management of labyrinthine fistulae in chronic otitis media with cholesteatoma. Ann Otol 1974;(suppl 10):3-19.
2. Sheehy JL, Brackmann DE. Cholesteatoma surgery: management of the labyrinthine fistula - a report of 97 cases. Laryngoscope 1979;89:78-87.
3. Sanna M, Zini C, Gamoletti R, et al. Closed versus open technique in the management of labyrinthine fistulae. Am J Otol 1988;9:470-5.
4. Palva T, Karja J, Palva A. Immediate and short-term complications of chronic ear surgery. Arch Otolaryngol 1976;102:137-9.
5. Antonelli PJ, Briggs RD, Gerhardt KJ. Hearing preservation with labyrinthine ablation in otitis media. Laryngoscope 2000;110:779-86.
6. Sedwick JD, Prevatt AR, Gajewski BJ, et al. Hearing loss with labyrinthine fistulae in Pseudomonas aeruginosa induced chronic suppurative otitis media. Otolaryngol Head Neck Surg 2001;125:P114.
7. Stenqvist M, Rask-Andersen H, Anniko M. Cochlear changes following destruction of semicircular canal in healthy and previously toxin-exposed rats. Acta Otolaryngol 1997;117:681-8.
8. Xiong YQ, Vasil ML, Johnson Z, et al. The oxygen- and iron-dependent sigma factor pvdS of Pseudomonas aeruginosa is an important virulence factor in experimental infective endocarditis. J Infect Dis 2000;181:1020-6.
9. Giebink GS, Wright PF. Different virulence of influenza A virus strains and susceptibility to pneumococcal otitis media in chinchillas. Infect Immun 1983;41:913-20.
10. Gajewski BJ, Sedwick JD, Antonelli PJ. A log-normal distribution model of the effect of bacteria and ear fenestration on hearing loss: a Bayesian approach. Stat Med.
11. Bowater RJ, Copas JB, Machado OA, et al. Hearing impairment and the log-normal distribution. Appl Stat 1996;45:203-17.
12. Longford NT. Random coefficient models. Oxford: Oxford University Press; 1993. pp 175-84.
13. Woods DE, Cryz SJ, Friedman RL, et al. Contribution of toxin A and elastase to virulence of Pseudomonas aeruginosa in chronic lung infections of rats. Infect Immun 1982;36:1223-8.
14. Stenqvist M, Anniko M, Pettersson A. Effect of Pseudomonas aeruginosa exotoxin A on inner ear function. Acta Otolaryngol 1997;117:73-9.
15. Lory S, Tai PC. Biochemical and genetic aspects of Pseudomonas aeruginosa virulence. Curr Top Microbiol Immunol 1985;118:53-69.
16. Iglewski BH, Burns RP, Gipson IK. Pathogenesis of corneal damage from pseudomonas exotoxin A. Invest Ophthalmol Vis Sci 1977;16:73-6.
17. Takeuchi N, Anniko M. Dexamethasone modifies the effect of Pseudomonas aeruginosa exotoxin A on hearing. Acta Otolaryngol 2000;120:363-8.
18. Popa R, Anniko M, Takumida M. Otoprotectant minimizes hearing defects caused by Pseudomonas aeruginosa exotoxin A. Acta Otolaryngol 2000;120:350-8.
19. El-Zaim HS, Chopra AK, Peterson JW, et al. Protection against exotoxin A (ETA) and Pseudomonas aeruginosa infection in mice with ETA-specific antipeptide antibodies. Infect Immun 1998;66:5551-4.
20. Sato K, Quartey MK, Liebeler CL, et al. Timing of penicillin treatment influences the course of Streptococcus pneumoniae-induced middle ear inflammation. Antimicrob Agents Chemother 1995;39:1896-8.